Endometrial Cavity Fluid Before Frozen Embryo Transfer: A Critical Review of Prognostic Significance and Evidence for Cycle Cancellation
- 1The Second Clinical Medical School, Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, 450046, People’s Republic of China
- 2Henan Province Hospital of Traditional Chinese Medicine (Second Affiliated Hospital of Henan University of Traditional Chinese Medicine), Zhengzhou, Henan, 450002, People’s Republic of China
Abstract
Endometrial cavity fluid during preparation for frozen embryo transfer creates uncertainty about proceeding, reassessing, or deferring treatment. This critical narrative review examines how assessment timing, fluid trajectory, and underlying pathology influence prognosis and the interpretation of cancellation studies. Focused searches were updated through October 20, 2026; this was not a systematic review or meta-analysis. In a cohort of 1034 frozen blastocyst transfers, live birth rates after fluid resolution and without fluid were 35.2% and 34.2%, respectively (adjusted risk ratio 1.00, 95% confidence interval 0.70–1.50). In 4308 single euploid transfers, fluid persisting at the decision for progesterone initiation or ovulation triggering was associated with a lower live birth rate than no fluid (38.3% vs 58.5%; adjusted odds ratio 0.50, 95% confidence interval 0.28–0.88). These assessments are not interchangeable with transfer-day fluid. Subsequent-transfer analyses after cancellation exclude patients who never reach another transfer and cannot establish a cumulative live birth benefit. Deferral can add visits, costs, and distress; any effect on treatment discontinuation or cumulative live birth remains unquantified specifically for cavity fluid. A practical assessment should distinguish resolved fluid, diagnosed tubal or uterine pathology, and persistent unexplained collections. Cause-specific treatment has a different evidence base from empirical aspiration or hormonal changes. No direct randomized comparison of proceeding with vs canceling frozen embryo transfer was identified. Multicenter trials should evaluate cumulative live birth and time to live birth from a common decision point, retaining all assigned patients.
Related
- Prognostic Significance of Amino Acid Transporters in Endometrial Cancer
- Apparent diffusion coefficient values on MRI as biomarkers for pre operative prediction of prognostic factors in endometrial cancer
- Prognostic significance and clinicopathologic prediction of tumor deposits in non-metastatic colon mucinous adenocarcinoma
- Prognostic Significance of Serum Sodium in Patients With Acute Pulmonary Embolism
- Prognostic Significance of CD47 and DHX9 in Metastatic Rectal Cancer
BibTeX
@article{ma2026endometrial,
title = {{Endometrial Cavity Fluid Before Frozen Embryo Transfer: A Critical Review of Prognostic Significance and Evidence for Cycle Cancellation}},
author = {Yujie Ma and Jinying Fu},
journal = {International Journal of Women's Health},
year = {2026},
month = nov,
doi = {10.2147/ijwh.s656172},
url = {https://doi.org/10.2147/ijwh.s656172},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Endometrial Cavity Fluid Before Frozen Embryo Transfer: A Critical Review of Prognostic Significance and Evidence for Cycle Cancellation
AU - Yujie Ma
AU - Jinying Fu
PY - 2026
DA - 2026/11/08
JO - International Journal of Women's Health
DO - 10.2147/ijwh.s656172
UR - https://doi.org/10.2147/ijwh.s656172
AB - Endometrial cavity fluid during preparation for frozen embryo transfer creates uncertainty about proceeding, reassessing, or deferring treatment. This critical narrative review examines how assessment timing, fluid trajectory, and underlying pathology influence prognosis and the interpretation of cancellation studies. Focused searches were updated through October 20, 2026; this was not a systematic review or meta-analysis. In a cohort of 1034 frozen blastocyst transfers, live birth rates after fluid resolution and without fluid were 35.2% and 34.2%, respectively (adjusted risk ratio 1.00, 95% confidence interval 0.70–1.50). In 4308 single euploid transfers, fluid persisting at the decision for progesterone initiation or ovulation triggering was associated with a lower live birth rate than no fluid (38.3% vs 58.5%; adjusted odds ratio 0.50, 95% confidence interval 0.28–0.88). These assessments are not interchangeable with transfer-day fluid. Subsequent-transfer analyses after cancellation exclude patients who never reach another transfer and cannot establish a cumulative live birth benefit. Deferral can add visits, costs, and distress; any effect on treatment discontinuation or cumulative live birth remains unquantified specifically for cavity fluid. A practical assessment should distinguish resolved fluid, diagnosed tubal or uterine pathology, and persistent unexplained collections. Cause-specific treatment has a different evidence base from empirical aspiration or hormonal changes. No direct randomized comparison of proceeding with vs canceling frozen embryo transfer was identified. Multicenter trials should evaluate cumulative live birth and time to live birth from a common decision point, retaining all assigned patients.
SN - 1179-1411
ER -